Crescent Biopharma grants employee options to buy 11,775 shares
CBIO•Crescent Biopharma approved options to purchase 11,775 ordinary shares for one non-executive employee on November 2, 2026.
1. Option award terms
The inducement options have a 10-year term and an exercise price of $12.91 per share. They vest 25% on the first anniversary of the employee’s start date, with the remainder vesting monthly in 1/48 installments, subject to continued service.
